CBD Patents
Read me first:
United States Patent 6,630,507
Cannabinoids as antioxidants and neuroprotectants
United States Patent 20130059018
PhytoCannabinoids in the treatment of cancer
United States Patent 5,538,993
Compounds according to the present invention are characterized by various beneficial properties such as analgesic, anti-emetic, sedative, anti-inflammatory, anti-glaucoma, and neuroprotective activities
United States Patent 6,448,288
Use of Cannabinoid compounds for inhibiting, inducing apoptosis, antitumoral action
United States Patent 4,876,276
Special use in cases of acute and of chronic pain
United States Patent 7,179,800
Useful for therapy, especially in the treatment of pain, inflammation and autoimmune disease
United States Patent 4837228
Cannabichromene (CBC) patented as reducing inflammation
United States Patent 4189491
Tetrahydrocannabinol (THC) patented as helping alleviate glaucoma
United States Patent 5631297
Anandamides treat intraocular hypertension
United States Patent 6132762
A transcutaneous therapeutic formulation utilizing marijuana lessening pain, inflammation, arthritis
United States Patent 6410588
Cannabinoids, such as cannabidiol can be used to treat inflammatory diseases. Cannabinoids for use in anti-inflammation, methods of treating inflammatory diseases and cannabinoids in combination with pharmaceutically acceptable carriers are claimed.
United States Patent 7597910
Zinc-enriched cannabis plant material, shiitake mushrooms, and maitake mushrooms Alleviate pain, swelling, inflammation of prostate conditions
United States Patent 8071641
Cannabidiol (CBD) patented for Prevention of diabetes
United States Patent 8242178
Cannabidiol (CBD) patented for Autoimmune hepatitis
United States Patent 8034843
Cannabidiol (CBD) and cannabidiolic acid (CBDA) Remedy for nausea, vomiting, emesis, motion sickness
United States Patent 20100292345
Cannabigerol (CBG) for pain, neurodegenerative disease, brain injury or damage, inflammatory or autoimmune disease, cachexia, nausea vomiting, movement disorders, rheumatoid arthritis, asthma, allergy, psoriasis, Crohn’s disease, lupus erythematosus, diabetes, cancer, osteoporosis, renal ischemia
United States Patent 20110257256
Δ9-Tetrahydrocannabinol (THC), cannabidiol (CBD) patented for dementia, cognitive impairment
United States Patent 20100222437
Cannabidiol and Denbinobin patented for Gastrointestinal inflammatory diseases, cancer prevention
United States Patent 20080262099
Cannabinol (CBD) inhibiting tumor cell migration (spreading of cancer cells)
United States Patent 20100204312
Cannabidiol (CBD) alone or in combination with THC to treat cell proliferation disorders
United States Patent 20090312414
Tetrahydrocannabinol (THC) and cannabinoids such as CBD help lower urinary tract infection, overactive bladder
United States Patent 20090197941
Cannabidiol (CBD) and ∆9-tetrahydrocannabinol (THC) Chronic Obstructive Pulmonary Disease (COPD)
United States Patent 20080181942
∆9-tetrahydrocannabinol (THC) to treat Multiple Sclerosis